Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
BioVivabioviva-science.com · Low evidenceBioViva Sciences develops AAV and CMV gene therapies aimed at lengthening healthy human lifespans by targeting cellular aging. The company's CMV platform supports larger genetic payloads to treat complex aging-related diseases with fewer treatments.
Parse Score